The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK

• Jamie Inshaw ,

  * E-mail: j.inshaw@ucl.ac.uk

  Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• Clifford Leen,

  Affiliation Western General Hospital, Edinburgh, United Kingdom

  ⨯
• Martin Fisher †,

  † Deceased.

  Affiliation Brighton and Sussex University NHS Trust, Brighton, United Kingdom

  ⨯
• Richard Gilson,

  Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

  ⨯
• David Hawkins,

  Affiliation Chelsea and Westminster Hospital, London, United Kingdom

  ⨯
• Simon Collins,

  Affiliation HIV i-Base, London, United Kingdom

  ⨯
• Julie Fox,

  Affiliation Guy’s and St. Thomas NHS Trust at Kings College, London, United Kingdom

  ⨯
• Ken McLean,

  Affiliation Charing Cross Hospital, London, United Kingdom

  ⨯
• Sarah Fidler,

  Affiliation Imperial College NHS Trust, London, United Kingdom

  ⨯
• Andrew Phillips,

  Affiliation Department of Infection and Population Health, University College London, London, United Kingdom

  ⨯
• Sam Lattimore,

  Affiliation Public Health England, London, United Kingdom

  ⨯
• Abdel Babiker,

  Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• Kholoud Porter,

  Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom

  ⨯
• UK HIV Seroconverters Cohort

  ¶Membership of the UK HIV Seroconverters Cohort is listed in the Acknowledgments.

  ⨯